PharmaBoardroom

Healthcare Politics in 2019

Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis. In this article, he gives his predictions for the political landscape in…

PJ Brooks – Program Officer, Division of Clinical Innovation…

PJ Brooks PhD, program director in the Office of Rare Diseases Research at the National Center for Advancing Translational Sciences (NCATS), National…

The Long and Short of Drug Shortages in America

Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) weighs in on the issue of drug shortages in…

2018 Venture Investment Activity in Life Sciences

David H. Crean, PhD, Managing Director for Objective Capital Partners, a leading investment banking advisory firm examines the venture investment…

The NFL’s Opioid Crisis: Is Cannabis the Answer?

With an increasing number of NFL players relying on potentially dangerous prescription painkillers, does the league need to relax its attitude to…

How the USA’s CREATES Act Restores Competition to the…

Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) discusses the Creating and Restoring Equal…

Elevated Valuations Across the Board for Life Sciences in 2018

David H. Crean, PhD, Managing Director for Objective Capital Partners, a leading investment banking advisory firm examines the healthcare market for…

Digital Transformation in Healthcare Marketing

Buck Dossey, an expert in digital marketing and audience manager at Adobe, discusses consumer needs in healthcare and the importance of adopting a…

Jeopardizing US Patients’ Health Is An Unacceptable…

Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) in the United States, discusses the…

Pfizer and Bain team up to launch Cerevel Therapeutics

Pfizer has teamed up with Bain Capital to launch Cerevel Therapeutics, a biopharmaceutical company based in Boston that will focus on developing…

Engaging Patients and Communities for Better Outcomes

After her son was diagnosed with SYNGAP1 - an extremely rare gene mutation - Monica founded Bridge the Gap – SYNGAP Education and Research…

California cannabis company launches opioid alternative

The opioid epidemic has reached new heights of late, claiming an estimated 40,000 American lives every year. The highly addictive nature of…

Tagged with USA